Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating gepotidacin for uncomplicated urinary tract infection has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• gepótidacin (gepoticin? wait)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Urinary Tract Infections | Phase 3 | Status: COMPLETED | Results posted: 2023-06-22